SG Americas Securities LLC Sells 68,402 Shares of AdaptHealth Corp. $AHCO

SG Americas Securities LLC lowered its stake in shares of AdaptHealth Corp. (NASDAQ:AHCO) by 87.5% during the first quarter, HoldingsChannel reports. The fund owned 9,739 shares of the company’s stock after selling 68,402 shares during the quarter. SG Americas Securities LLC’s holdings in AdaptHealth were worth $116,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently bought and sold shares of AHCO. Rockefeller Capital Management L.P. increased its holdings in shares of AdaptHealth by 433.0% during the 4th quarter. Rockefeller Capital Management L.P. now owns 2,585 shares of the company’s stock worth $26,000 after purchasing an additional 2,100 shares during the period. FNY Investment Advisers LLC bought a new position in AdaptHealth during the third quarter valued at about $35,000. PNC Financial Services Group Inc. increased its stake in AdaptHealth by 22.3% during the fourth quarter. PNC Financial Services Group Inc. now owns 7,003 shares of the company’s stock valued at $70,000 after acquiring an additional 1,279 shares during the period. Tower Research Capital LLC TRC raised its holdings in AdaptHealth by 318.0% in the 2nd quarter. Tower Research Capital LLC TRC now owns 9,592 shares of the company’s stock valued at $90,000 after acquiring an additional 7,297 shares in the last quarter. Finally, Tidal Investments LLC acquired a new position in AdaptHealth in the 2nd quarter valued at approximately $96,000. 82.67% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at AdaptHealth

In other AdaptHealth news, insider Russell E. Schuster III sold 11,275 shares of the stock in a transaction on Monday, June 1st. The stock was sold at an average price of $10.06, for a total transaction of $113,426.50. Following the completion of the transaction, the insider directly owned 136,538 shares in the company, valued at $1,373,572.28. This represents a 7.63% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.95% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

AHCO has been the topic of a number of research reports. Weiss Ratings restated a “sell (d)” rating on shares of AdaptHealth in a research report on Friday, May 22nd. Wall Street Zen raised AdaptHealth from a “hold” rating to a “buy” rating in a research report on Sunday, June 14th. Royal Bank Of Canada boosted their price target on shares of AdaptHealth from $13.00 to $15.00 and gave the company an “outperform” rating in a report on Monday, May 11th. Robert W. Baird dropped their price objective on shares of AdaptHealth from $18.00 to $15.00 and set an “outperform” rating for the company in a research note on Monday, July 6th. Finally, Canaccord Genuity Group raised their price objective on shares of AdaptHealth from $14.00 to $16.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. Six investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, AdaptHealth presently has an average rating of “Moderate Buy” and a consensus target price of $13.86.

AdaptHealth Trading Up 0.7%

Shares of AHCO opened at $10.29 on Tuesday. The company has a current ratio of 0.92, a quick ratio of 0.71 and a debt-to-equity ratio of 1.21. The stock has a market cap of $1.40 billion, a PE ratio of -16.60, a PEG ratio of 0.52 and a beta of 1.45. AdaptHealth Corp. has a 1 year low of $8.51 and a 1 year high of $13.43. The stock has a 50 day simple moving average of $10.32 and a 200-day simple moving average of $10.61.

AdaptHealth Company Profile

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.